- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00312559
The Therapeutics Effects of Yoga in Individuals With Parkinson's Disease
August 17, 2007 updated by: University of Kansas
The Therapeutic Effects of Yoga in Individuals With Parkinson's Disease
To determine if yoga is beneficial in improving physical function quality of life and medical status in people with Parkinson's disease
Study Overview
Detailed Description
This pilot study is a randomized controlled study of 20-30 individuals with Parkinson's disease will have a control group with no training and a research group with yoga training.
The control group will have the opportunity to attend yoga training of the same intensity after the study is completed.
The effects of yoga will not be on the control group.
Data on physical function will be derived from assessments including strength, balance, flexibility, ROM.
gait, posture and functional analysis performed in the Georgia Holland Cardiopulmonary and Neuromuscular Research Lab.
Questionnaires related to quality of life, depression and falls will determine psychological impact or yoga training.
Vital signs, pulmonary function tests and blood draws will be done in the General Clinical research Center (GCRC) and protein analysis will be done in the diabetes research lab.
Study Type
Interventional
Enrollment
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Kansas
-
Kansas City, Kansas, United States, 66160
- University of Kansas Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Parkinson's Disease
- Stage 1-3 Hoehn & Yahr
Exclusion Criteria:
- Decline in immune function
- 6 month joint surgery
- spinal fusions
- decline in mental status measured by Folstein Mini Mental Status Exam
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Pulmonary function test, serum protein levels BP, HR, RR, strength testing using microFET, flexibility and range of motion testing using goniometer, balance/posture gait optitrk system, Berg balance scale
|
Secondary Outcome Measures
Outcome Measure |
---|
Unified Parkinson's Disease Rating Scale
|
Hoehn & Yahr Classification Scale
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Yvonne Searls, PT, PhD, University of Kansas Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2006
Study Completion (Actual)
March 1, 2007
Study Registration Dates
First Submitted
April 6, 2006
First Submitted That Met QC Criteria
April 6, 2006
First Posted (Estimate)
April 10, 2006
Study Record Updates
Last Update Posted (Estimate)
August 20, 2007
Last Update Submitted That Met QC Criteria
August 17, 2007
Last Verified
August 1, 2007
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10214 (Other Identifier: CTEP)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson's Disease
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
Assistance Publique - Hôpitaux de ParisFrance Parkinson AssociationUnknownHealthy Controls | Parkinson's Disease With LRRK2 Mutation | Parkinson's Disease Without LRRK2 MutationFrance
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
Universidade Federal de PernambucoCompletedParkinson's Disease.Brazil
-
University Hospital, GrenobleCompletedParkinson's Disease (Disorder)France
-
Shanghai East HospitalShanghai iCELL Biotechnology Co., Ltd, Shanghai, ChinaRecruitingIdiopathic Parkinson's DiseaseChina
-
Beijing Tiantan HospitalRecruitingPD - Parkinson's DiseaseChina
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedIdiopathic Parkinson's DiseaseUnited States, Canada, Czechia, Germany, Israel, Italy, Poland, Serbia
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedIdiopathic Parkinson's DiseaseUnited States, Canada, Czechia, Germany, Israel, Italy, Poland, Serbia
-
AbbVieActive, not recruitingParkinson's Disease (PD)United States, Australia
Clinical Trials on Yoga Training
-
Angus YuThe Hong Kong Jockey Club Charities TrustCompleted
-
Chulalongkorn UniversityCompleted
-
University of CincinnatiWithdrawnHeart Failure, SystolicUnited States
-
Dhanunjaya Lakkireddy, MD, FACCCompletedAtrial FibrillationUnited States
-
Riphah International UniversityCompletedPrimary DysmenorrheaPakistan
-
Medipol UniversityCompleted
-
Duke UniversityCompletedConcussionUnited States
-
Istanbul Medipol University HospitalCompleted